Thursday, July 11, 2013 6:47:31 PM
1)Its all about LymPro short term; Gerald eluded to the reality that a program update is coming within a few weeks.
2) MANF Orphan indications/clinical data update is coming over the next few weeks as well.
What do you people want and expect realistically? LymPro is moving further along and we are in striking distance of a possible partnership.
MANF Orphan data will be the quickest path to potential commercialization with that drug program (the data is almost on our doorstep).
Have faith and just let things play out ..keep it simple.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM